Cargando…

Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study

OBJECTIVE: The effect of physiological dose growth hormone (GH) replacement therapy on bone mineral density (BMD) in adults with growth hormone deficiency (GHD) is not well defined. We aimed to investigate the effects of 18 months of treatment with recombinant human growth hormone (rhGH) at physiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ya-Yin, Ma, Jia-Ni, Ren, Zi-Yu, Liu, Jie, Zhou, Xin-Yi, Xie, Xue-Rui, Ren, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081901/
https://www.ncbi.nlm.nih.gov/pubmed/37033470
http://dx.doi.org/10.1155/2023/4988473
_version_ 1785021212248768512
author Shen, Ya-Yin
Ma, Jia-Ni
Ren, Zi-Yu
Liu, Jie
Zhou, Xin-Yi
Xie, Xue-Rui
Ren, Wei
author_facet Shen, Ya-Yin
Ma, Jia-Ni
Ren, Zi-Yu
Liu, Jie
Zhou, Xin-Yi
Xie, Xue-Rui
Ren, Wei
author_sort Shen, Ya-Yin
collection PubMed
description OBJECTIVE: The effect of physiological dose growth hormone (GH) replacement therapy on bone mineral density (BMD) in adults with growth hormone deficiency (GHD) is not well defined. We aimed to investigate the effects of 18 months of treatment with recombinant human growth hormone (rhGH) at physiological doses on BMD, body composition (BC), and quality of life (QoL). METHODS: Sixty-eight patients diagnosed with adult growth hormone deficiency (AGHD) in our hospital were included in this retrospective study. All patients received individualized rhGH replacement to maintain normal serum insulin-like growth factor-1 (IGF-1) levels. BMD and BC measurements were performed by dual energy X-ray absorptiometry (DXA). Excluding those with incomplete follow-up data, we analyzed BMD in 68 patients, as well as BC and QoL in 36 of them. RESULTS: Compared with the baseline, lumbar spine BMD decreased by 0.008 g/cm(2) (P=0.006) and increased by 0.011 g/cm(2) (P=0.045) at month 18, and total hip BMD decreased by 0.005 g/cm(2) (P=0.008) and did not change significantly from the baseline at month 18. The changes in BMD did not differ by sex, and the increase in BMD was more pronounced in patients with low Z-scores at the baseline (lumbar spine: P=0.005 and total hip: P=0.018). The percentage change from the baseline in BMD was greater for the lumbar spine than for the total hip (P=0.003). Lean body mass (LBM) increased significantly (P=0.012), total body fat ratio (TBF%) decreased significantly (P=0.011), visceral adipose tissue (VAT) decreased significantly (P=0.016), and QoL improved significantly (P < 0.001). CONCLUSIONS: Within 18 months of treatment, bone resorption manifested first, BMD decreased to a nadir at month 6, and then it increased. The increase in BMD was greater in the lumbar spine than in the hip, and the increase was more pronounced in patients with low BMD. Eighteen months of rhGH replacement therapy significantly improved lumbar spine BMD and improved BC and QoL.
format Online
Article
Text
id pubmed-10081901
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-100819012023-04-08 Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study Shen, Ya-Yin Ma, Jia-Ni Ren, Zi-Yu Liu, Jie Zhou, Xin-Yi Xie, Xue-Rui Ren, Wei Int J Endocrinol Research Article OBJECTIVE: The effect of physiological dose growth hormone (GH) replacement therapy on bone mineral density (BMD) in adults with growth hormone deficiency (GHD) is not well defined. We aimed to investigate the effects of 18 months of treatment with recombinant human growth hormone (rhGH) at physiological doses on BMD, body composition (BC), and quality of life (QoL). METHODS: Sixty-eight patients diagnosed with adult growth hormone deficiency (AGHD) in our hospital were included in this retrospective study. All patients received individualized rhGH replacement to maintain normal serum insulin-like growth factor-1 (IGF-1) levels. BMD and BC measurements were performed by dual energy X-ray absorptiometry (DXA). Excluding those with incomplete follow-up data, we analyzed BMD in 68 patients, as well as BC and QoL in 36 of them. RESULTS: Compared with the baseline, lumbar spine BMD decreased by 0.008 g/cm(2) (P=0.006) and increased by 0.011 g/cm(2) (P=0.045) at month 18, and total hip BMD decreased by 0.005 g/cm(2) (P=0.008) and did not change significantly from the baseline at month 18. The changes in BMD did not differ by sex, and the increase in BMD was more pronounced in patients with low Z-scores at the baseline (lumbar spine: P=0.005 and total hip: P=0.018). The percentage change from the baseline in BMD was greater for the lumbar spine than for the total hip (P=0.003). Lean body mass (LBM) increased significantly (P=0.012), total body fat ratio (TBF%) decreased significantly (P=0.011), visceral adipose tissue (VAT) decreased significantly (P=0.016), and QoL improved significantly (P < 0.001). CONCLUSIONS: Within 18 months of treatment, bone resorption manifested first, BMD decreased to a nadir at month 6, and then it increased. The increase in BMD was greater in the lumbar spine than in the hip, and the increase was more pronounced in patients with low BMD. Eighteen months of rhGH replacement therapy significantly improved lumbar spine BMD and improved BC and QoL. Hindawi 2023-03-31 /pmc/articles/PMC10081901/ /pubmed/37033470 http://dx.doi.org/10.1155/2023/4988473 Text en Copyright © 2023 Ya-Yin Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Ya-Yin
Ma, Jia-Ni
Ren, Zi-Yu
Liu, Jie
Zhou, Xin-Yi
Xie, Xue-Rui
Ren, Wei
Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title_full Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title_fullStr Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title_full_unstemmed Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title_short Effects of 18 Months of Growth Hormone Replacement Therapy on Bone Mineral Density in Patients with Adult Growth Hormone Deficiency: A Retrospective Study
title_sort effects of 18 months of growth hormone replacement therapy on bone mineral density in patients with adult growth hormone deficiency: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081901/
https://www.ncbi.nlm.nih.gov/pubmed/37033470
http://dx.doi.org/10.1155/2023/4988473
work_keys_str_mv AT shenyayin effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT majiani effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT renziyu effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT liujie effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT zhouxinyi effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT xiexuerui effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy
AT renwei effectsof18monthsofgrowthhormonereplacementtherapyonbonemineraldensityinpatientswithadultgrowthhormonedeficiencyaretrospectivestudy